logo
  • Patient
  • Discover
    • The ICAN IHU
      • What is an IHU?
      • Identity
      • The governance
      • Recruitment
      • Operational teams
      • News
    • Communication
      • Press area
      • Document library
      • Newsletter
      • Videos
    • Training
      • IHU ICAN summer camp
      • ICAN Scientific Seminars
  • Health
    • Clinical teams
    • Cardiometabolism
      • What is cardiometabolism?
      • Diabetes
      • Obesity
      • Fatty Liver Disease (NASH)
      • Diseases of the heart and vessels
    • Innovative treatment journeys
      • NASH Clinic
      • Bariatric Surgery
      • Familial hypercholesterolemia
      • Heart failure
    • Reference centers
      • PRADORT Rare Diseases Reference Center
      • Reference Center for Hereditary or Rare Heart Diseases
      • Reference center for rare pathologies of insulin-secretion and insulin-sensitivity
      • Reference Center for Inflammatory Biliary Tract Diseases and Autoimmune Hepatitis
      • Reference Center for Rare Endocrine Diseases of Growth and Development
      • Reference Center for Rare Gynecological Diseases
  • Research
    • Research teams
      • Scientists progress
      • Scientific outreach
      • All our scientific publications
    • Scientists progress
    • Scientific outreach
    • Lines of research
      • Biology of cardiometabolic diseases
      • Imagery
      • Big Data
      • Cohorts
  • Collaborate
    • Project set-up assistance
      • Valuation
    • Valuation
    • Clinic investigation
      • ICAN Clinical Investigation
      • Patient
    • Scientific platforms
      • ICAN Omics
      • ICAN BioCollection
      • ICAN BioCell Flow Cytometry
      • ICAN BioCell Human Liver Biology
      • ICAN Imaging
      • ICAN I/O – Data sciences
      • ICAN BioCell iPS
    • Partnerships
      • R&D collaborations
      • Academic partnerships
      • Medications
      • Medical devices
      • e-Health
  • Support
    • Why support ICAN ?
      • 7 good reasons
      • What are your donations for ?
      • They support us
    • How to support ICAN ?
      • How to support us?
      • Tax deductions
      • Make a donation
  • Make a donation
  • Français
  • Search

2 March 2023

Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort

2 March 2023

International survey of neuromonitoring and neurodevelopmental outcome in children and adults supported on extracorporeal membrane oxygenation in Europe

1 March 2023

Association Between Shock Etiology and 5-Year Outcomes After Venoarterial Extracorporeal Membrane Oxygenation

1 March 2023

Primary cardiovascular prevention in people with HIV: what’s the score?

28 February 2023

T-cell dysregulation and inflammatory process in Gcn2 (Eif2ak4-/-) deficient rats in basal and stress conditions

24 February 2023

Strategies to safely rule out pulmonary embolism in COVID-19 outpatients: a multicenter retrospective study

21 February 2023

Perinatal, metabolic, and reproductive features in PPARG-related lipodystrophy

20 February 2023

Recurrences of Atrial Fibrillation Despite Durable Pulmonary Vein Isolation: The PARTY-PVI Study

18 February 2023

Evaluation of PXL065 – Deuterium-Stabilized (R)-Pioglitazone in NASH Patients: a Phase 2 randomized placebo-controlled trial (DESTINY-1)

14 February 2023

Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammation

9 February 2023

Management of comatose survivors of out-of-hospital cardiac arrest in Europe: current treatment practice and adherence to guidelines

8 February 2023

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference

8 February 2023

Clinical impact of successful cardioversion for new-onset atrial fibrillation in critically ill septic patients: A preliminary study

4 February 2023

Quality indicators for post-resuscitation care after out-of-hospital cardiac arrest

3 February 2023

[Respiratory manifestations of Ehlers-Danlos syndromes]

1 February 2023

Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial

Ce site utilise des cookies afin de vous proposer une navigation optimale, de réaliser des mesures d’audience et de promouvoir le don.
ParamètresAccepterRefuser
Manage consent

Paramètres des cookies

Ce site Web utilise des cookies pour améliorer votre expérience lorsque vous naviguez sur le site Web. Parmi ceux-ci, les cookies classés comme nécessaires sont stockés sur votre navigateur car ils sont essentiels au fonctionnement des fonctionnalités de base du site Web. Nous utilisons également des cookies tiers qui nous aident à analyser et à comprendre comment vous utilisez ce site Web. Ces cookies ne seront stockés dans votre navigateur qu'avec votre consentement. Vous avez également la possibilité de désactiver ces cookies. Mais la désactivation de certains de ces cookies peut affecter votre expérience de navigation.
Marketing
Advertising cookies such as those of Facebook are used to display relevant advertisements to visitors and for the implementation of marketing campaigns.
Statistics
Statistics cookies are used to understand how visitors interact with the website.
SAVE & ACCEPT
Powered by CookieYes Logo